Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • Snibe Showcases The World's Fastest CLIA System at MEDICA 2018

    MEDICA, the leading international trade fair for the medical sector, was held in Düsseldorf, Germany, from Nov. 12 to 15. At this year's Medica, Snibe, as the leading company for Chemiluminescence Immunoassay, once again charmed the expo visitors with a line-up of laboratory innovations displaying in its spectacularly-designed stand.
    Issue date:2018-11-14
  • Snibe shines at AACC 2018

    The 70th AACC Annual Scientific Meeting & Clinical Lab Expo., attracting more than 22,000 visitors and 500 exhibitors to share the most recent technology available in the medical laboratory market, was held at McCormick Place, Chicago, USA from Jul. 29 to Aug. 2.
    Issue date:2018-08-01

New Product

More >>

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 23years

139Countries

9000Units

More